Zhang, Xue-Hong <br/><br/>
The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo.  [electronic resource] 

 -  BioFactors (Oxford, England)  Nov 2017 
 - 812-820 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-8081 
<br/><br/><label>Standard No.: </label>10.1002/biof.1380  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Digoxin--pharmacology<br/>Drug Combinations<br/>Drug Synergism<br/>Female<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>Indoles--pharmacology<br/>K562 Cells<br/>Leukemia, Erythroblastic, Acute--drug therapy<br/>Mice<br/>Mice, Nude<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>THP-1 Cells<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays